Login/Sign Up
₹145
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Olmevac CL 20 Tablet is a prescription tablet used to treat high blood pressure (hypertension) when a single medicine is not enough. It combines two active ingredients to lower blood pressure, which helps prevent future heart attacks, strokes, and kidney problems.
To get the most benefit, you should take this medicine consistently at the same time every day, either with or without food. Along with taking Olmevac CL 20 Tablet, adopting a heart-healthy diet low in salt and staying physically active can significantly improve your blood pressure readings.
While taking Olmevac CL 20 Tablet, some people may experience mild side effects like dizziness, ankle swelling, or a mild headache. If you experience severe symptoms such as sudden swelling of the face, lips, or tongue, or if you feel extremely lightheaded, seek medical help immediately.
Before starting this medication, talk to your doctor or pharmacist if you have liver damage, severe kidney disease, or heart problems. Do not take this if you are pregnant, planning to become pregnant, or have a known allergy to any of its ingredients.
This medicine can interact with alcohol, which may cause your blood pressure to drop too low and make you feel dizzy. It also interacts with potassium supplements and other blood pressure drugs, so pregnant or breastfeeding women, as well as elderly individuals, should consult their healthcare provider before using Olmevac CL 20 Tablet.
Your doctor may prescribe this medicine to treat several conditions, including:
Taking Olmevac CL 20 Tablet provides long-term support for managing high blood pressure by helping maintain healthy blood pressure levels and protecting your cardiovascular system. Key benefits include:
Unsafe
Olmevac CL 20 Tablet can lower your blood pressure causing dizziness and drowsiness. It can also cause orthostatic hypotension (sudden fall in blood pressure while standing). So try to avoid intake of Olmevac CL 20 Tablet with alcoholic beverages.
Unsafe
Olmevac CL 20 Tablet is pregnancy risk category D medicine which may cause harm to the fetus or unborn baby. So, when pregnancy is detected, discontinue Olmevac CL 20 Tablet as soon as possible and consult the doctor.
Consult your doctor
Olmevac CL 20 Tablet passes into the breast milk. But its effect on the baby is not clear. However, contacting the doctor before intake of Olmevac CL 20 Tablet is advisable.
Unsafe
Olmevac CL 20 Tablet may cause side effects that could affect your ability to drive. Taking Olmevac CL 20 Tablet may lower your blood pressure
Caution
Olmevac CL 20 Tablet to be taken with caution, especially if you have a liver disease history. Your doctor will have to change the dosage depending on your medical condition and your reaction to treatment.
Consult your doctor
Olmevac CL 20 Tablet is not recommended in patients with chronic kidney disease (severe renal impairment). Please inform your doctor if you had a history of kidney disease. Your doctor may adjust the dose if required based on your condition.
Unsafe
Olmevac CL 20 Tablet is not recommended in children. The safety and efficacy of Olmevac CL 20 Tablet in children have not yet been established
Caution
Olmevac CL 20 Tablet is often prescribed to patients with heart problems to treat hypertension. However, it must be taken strictly under medical supervision, as it can affect liver and kidney function and may interact with other heart medications.
Caution
Olmevac CL 20 Tablet should be taken with caution in geriatric patients. Please inform your doctor before using Olmevac CL 20 Tablet.
Have a query?
The time required for Olmevac CL 20 Tablet to start to work: The time required for Olmevac CL 20 Tablet to show its action is not clinically established.
The time for which the effects of Olmevac CL 20 Tablet last: The duration of action for Olmevac CL 20 Tablet is not clinically established.
Inform your doctor if you are taking any of the following medicines, as they may interact with Olmevac CL 20 Tablet.
Login/Sign Up
Login/Sign Up
Disclaimer
